MARATTO

article · npj Aging

Association of potentially inappropriate prescribing with frailty among older adults with multimorbidity in Northwest Ethiopia

2026Open accessDebre Tabor University

Abstract

Abstract Potentially inappropriate prescribing (PIP), which encompasses both potentially inappropriate medications (PIM), potential prescribing omissions (PPO), has been associated with frailty, but this relationship has not been explored in Northwest Ethiopia. A multicenter hospital-based cross-sectional study was conducted from March to June 2025 among hospitalized older adults with multimorbidity. PIP was assessed using the Screening Tool of Older Person’s Prescriptions (STOPP) and Screening Tool to Alert Doctors to Right Treatment (START) criteria version 3, while frailty was evaluated using the Clinical Frailty Scale (CFS). Binary logistic regression was performed to identify factors associated with PIM, PPO, and frailty. Adjusted odds ratios (AOR) with 95% confidence intervals (CI) were calculated, and statistical significance was declared at P < 0.05. A total of 407 participants were included. The prevalence of PIP was 75.4% (95% CI, 71.5–79.4), and frailty was identified in 53.1% (95% CI, 48.2–58.0) of patients. Frailty was significantly associated with PIM, PPO, female gender, use of polypharmacy, and dependency in activities of daily living (ADL) in multivariable analysis. These findings highlight the importance of routine regular medication review and careful prescribing assessments in older adults with multimorbidity, particularly, those with frailty.

Research topics

  • Pharmaceutical Practices and Patient Outcomes
  • Chronic Disease Management Strategies
  • Frailty in Older Adults

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1038/s41514-026-00457-8

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.